However, their mechanism of action presents unique physiological hurdles that can derail athletic performance if not managed correctly.[2][3] The Mechanism: Why It Matters for Sport GLP-1 agonists work primarily by mimicking a hormone that targets areas of the brain that regulate appetite and food intake
Key findings at a glance For many people, injections are still the biggest barrier: A large number of eligible UK adults say they have avoided GLP-1 treatments because they do not want to inject themselves
The drugs, which contain the active substance semaglutide, work by mimicking a hormone called glucagon-like peptide-1 (GLP-1), which reduces appetite, leading to weight loss
This is the smallest group in clinical trials but a growing population in real-world use
The percentage of covered workers enrolled in self-funded plans is similar to the percentages five years ago (61%) and ten years ago (61%) [Figure 10.2]
Se trata de un programa de los CMS que no forma parte de ningn plan de Medicare de Aetna
